Dr. Daniel S. Berman[email protected]Nuclear MedicineScreening for CAD in diabetics: Which patient? Which test?Screening for coronary artery disease (CAD) in any population is controversial. In this editorial opinion, Dr. Daniel Berman of Cedars-Sinai Medical Center points out what he believes are shortcomings in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study published this week in the Journal of the American Medical Association.April 16, 2009Page 1 of 1Top StoriesMolecular ImagingIAEA recommends global adoption of PSMA-PETThe finding follows a trial involving 775 men with high-risk prostate cancer across 11 countries with varied income levels.Women’s Imaging PreviewRoad to RSNA 2025: Women's Imaging PreviewWomens ImagingPartial breast irradiation effective in women with HR+ cancersEconomicsMedicare updates 2026: Fee Schedule and impact on radiologySponsor ContentRevolutionizing Thyroid Imaging with DeepHealth AI